265 related articles for article (PubMed ID: 25772964)
1. Evolution of DNA sequencing.
Tipu HN; Shabbir A
J Coll Physicians Surg Pak; 2015 Mar; 25(3):210-5. PubMed ID: 25772964
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing and its applications in molecular diagnostics.
Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
[TBL] [Abstract][Full Text] [Related]
3. Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing.
Diekstra A; Bosgoed E; Rikken A; van Lier B; Kamsteeg EJ; Tychon M; Derks RC; van Soest RA; Mensenkamp AR; Scheffer H; Neveling K; Nelen MR
Clin Chem; 2015 Jan; 61(1):154-62. PubMed ID: 25274553
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
[TBL] [Abstract][Full Text] [Related]
5. [Next-generation DNA sequencing in clinical diagnostics].
Lacoste C; Fabre A; Pécheux C; Lévy N; Krahn M; Malzac P; Bonello-Palot N; Badens C; Bourgeois P
Arch Pediatr; 2017 Apr; 24(4):373-383. PubMed ID: 28242148
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
[TBL] [Abstract][Full Text] [Related]
7. Next generation sequencing and its applications in forensic genetics.
Børsting C; Morling N
Forensic Sci Int Genet; 2015 Sep; 18():78-89. PubMed ID: 25704953
[TBL] [Abstract][Full Text] [Related]
8. Critical review of NGS analyses for de novo genotyping multigene families.
Lighten J; van Oosterhout C; Bentzen P
Mol Ecol; 2014 Aug; 23(16):3957-72. PubMed ID: 24954669
[TBL] [Abstract][Full Text] [Related]
9. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
[TBL] [Abstract][Full Text] [Related]
10. Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations.
Chin EL; da Silva C; Hegde M
BMC Genet; 2013 Feb; 14():6. PubMed ID: 23418865
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
12. [Towards a national standardisation of NGS studies in the diagnosis of myopathies].
Krahn M; Cerino M; Campana-Salort E; Cossée M
Med Sci (Paris); 2017 Nov; 33 Hors série n°1():30-33. PubMed ID: 29139383
[No Abstract] [Full Text] [Related]
13. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
Mu W; Lu HM; Chen J; Li S; Elliott AM
J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing (NGS) in the microbiological world: How to make the most of your money.
Vincent AT; Derome N; Boyle B; Culley AI; Charette SJ
J Microbiol Methods; 2017 Jul; 138():60-71. PubMed ID: 26995332
[TBL] [Abstract][Full Text] [Related]
15. Low-Cost, High-Throughput Sequencing of DNA Assemblies Using a Highly Multiplexed Nextera Process.
Shapland EB; Holmes V; Reeves CD; Sorokin E; Durot M; Platt D; Allen C; Dean J; Serber Z; Newman J; Chandran S
ACS Synth Biol; 2015 Jul; 4(7):860-6. PubMed ID: 25913499
[TBL] [Abstract][Full Text] [Related]
16. HLA typing by next-generation sequencing - getting closer to reality.
Gabriel C; Fürst D; Faé I; Wenda S; Zollikofer C; Mytilineos J; Fischer GF
Tissue Antigens; 2014 Feb; 83(2):65-75. PubMed ID: 24447174
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing - feasibility and practicality in haematology.
Kohlmann A; Grossmann V; Nadarajah N; Haferlach T
Br J Haematol; 2013 Mar; 160(6):736-53. PubMed ID: 23294427
[TBL] [Abstract][Full Text] [Related]
18. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
Beck TF; Mullikin JC; ; Biesecker LG
Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Single Gene Analyses Beyond Sanger.
Najm J; Rath M; Schröder W; Felbor U
Hamostaseologie; 2018 Aug; 38(3):158-165. PubMed ID: 30261521
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of next-generation sequencing, denaturing gradient gel electrophoresis, clonal restriction fragment length polymorphism and cloning-sequencing as methods for characterizing commercial microbial consortia.
Samarajeewa AD; Hammad A; Masson L; Khan IU; Scroggins R; Beaudette LA
J Microbiol Methods; 2015 Jan; 108():103-11. PubMed ID: 25479430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
